Log In
BCIQ
Print this Print this
 

KBP-5074

  Manage Alerts
Collapse Summary General Information
Company Sihuan Pharmaceutical Holdings Group Ltd.
DescriptionNon-steroidal MR-specific antagonist
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard Indication Renal (unspecified)
Indication DetailsTreat chronic kidney disease (CKD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today